C
Originally published by Citizen DigitalJanuary 10, 2026
13h ago
Gov’t recommends registration of HIV prevention drug Lenacapavir
According to the Ministry of Health, the decision follows scientific research and review of the drug’s suitability for use in the country.The ministry said the drug wor.....
✨ Key Highlights
The Ministry of Health in Kenya has recommended the registration of Lenacapavir, a long-acting HIV prevention drug, to combat new infections. This decision follows a comprehensive scientific assessment of the drug's quality, safety, and efficacy.
- The drug, administered only twice a year, offers an alternative to daily oral HIV prevention medicines.
- Health Cabinet Secretary Aden Duale announced the recommendation on January 9, 2026, through the Pharmacy and Poisons Board.
- Kenya is among the first African countries to recommend Lenacapavir for registration, aligning with global public health guidance and WHO recommendations.
Continue Reading
Read the complete article from Citizen Digital
Advertisement
Related News
Advertisement





